| This article has been cited by |
| 1 | | |
| Alfonso Hoyos-Martinez,Vincent E. Horne |
| .2022;()33 |
| [DOI] |
|
| 2 | Induction chemotherapy reduces extracellular heat shock protein 72 levels, inflammation, lipoperoxidation and changes insulin sensitivity in children and adolescents newly diagnosed with acute lymphoblastic leukemia | |
| Ana Paula Trussardi Fayh,Camila de Carvalho Gomes,Helena Trevisan Schroeder,Carlos Henrique de Lemos Muller,Telma Maria de Araújo Moura Lemos,Mauricio Krause |
| Oncotarget.2018;9(47)28784 |
| [DOI] |
|
| 3 | Blood glucose level during induction phase chemotherapy in childhood acute lymphoblastic leukemia | |
| Nunki Andria,Annang Giri Moelyo,Muhammad Reza |
| Paediatrica Indonesiana.2020;60(4)197 |
| [DOI] |
|
| 4 | Hypoglycemia during treatment of acute lymphoblastic leukemia | |
| Mary Jiang,Alexandra Ahmet |
| Paediatrics & Child Health.2023;28(5)305 |
| [DOI] |
|
| 5 | Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non-genetic risk factors in this group | |
| Thomas I. Hewat,Thomas W. Laver,Jayne A. L. Houghton,Jonna M. E. Männistö,Sabah Alvi,Stephen P. Brearey,Declan Cody,Antonia Dastamani,Miguel De los Santos La Torre,Nuala Murphy,Birgit Rami-Merhar,Birgit Wefers,Hanna Huopio,Indraneel Banerjee,Matthew B. Johnson,Sarah E. Flanagan |
| Pediatric Diabetes.2022;23(4)457 |
| [DOI] |
|
